Captopril CAS 62571-86-2 API Factory USP High Quality Anti-Hypertension
Ubonelelo lwabavelisi ngoBusulungekileyo obuPhezulu kunye noMgangatho oZinzileyo
Igama leKhemikhali: Captopril
CAS: 62571-86-2
I-Angiotensin-Converting Enzyme (ACE) Inhibitor Anti-Hypertension esebenzayo
Umgangatho ophezulu we-API, iMveliso yoRhwebo
| Igama leMchiza | Captopril |
| Izithethantonye | (S)-(-)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline;(S)-(-)-1-(3-Mercapto-2-methylpropionyl)-L-proline |
| Inombolo yeCAS | 62571-86-2 |
| Inombolo yeCAT | RF-API89 |
| Ubume beStokhwe | Kwi-Stock, iMveliso yeMveliso ukuya kumakhulu eeKilogram |
| Ifomula yeemolekyuli | I-C9H15NO3S |
| Ubunzima beMolekyuli | 217.29 |
| Uphawu | Ruifu Chemical |
| Into | Iinkcukacha |
| Imbonakalo | Mhlophe ukuya kuMhlophe oMhlophe wePowder |
| Isivavanyi | 98.0% ~ 102.0% (kwisiseko somisiwe) |
| Indawo yokunyibilika | 104.0 ~ 110.0℃ |
| Ujikelezo oluKhethekileyo lwe-Optical | -125.0 ° ukuya -134.0 ° |
| Ubumuncu | 7.0~8.0 |
| Ilahleko ekomisweni | ≤1.0% |
| Intsalela kwi-Ignition | ≤0.10% |
| Iintsimbi ezinzima | ≤20ppm |
| Izinto ezinxulumeneyo | |
| I-Captopril Disulfide | ≤1.0% |
| Ukungcola Okungaziwayo Ongatshatanga | ≤0.20% |
| Ukungcola ngokupheleleyo | ≤0.50% |
| Ukungcola okuguquguqukayo kwe-Organic | Iyahlangabezana neeMfuno |
| Umgangatho woVavanyo | Umgangatho woShishino |
| Ukusetyenziswa | Isetyenziswa njenge-Anti-Hypertension Medicament |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Captopril yeyona nto iphononongwa kakhulu kwi-angiotensin-converting enzyme (ACE) inhibitors ecetywayo njengechiza le-antihypertensive.Ithintela i-angiotensin-converting enzyme, ecinezela ukubunjwa kwe-angiotensin II kwaye ikhulula umphumo wayo we-vasoconstricting kwimithambo yegazi kunye ne-venous.Uxinzelelo jikelele lwe-vascular peripheral tension luyancipha, olukhokelela ekuthotyweni koxinzelelo lwe-arterial.I-Captopril, kunye nezinye i-ACE inhibitors, iboniswa kunyango lwe-hypertension, ukungaphumeleli kwentliziyo, ukungasebenzi kwe-ventricular yasekhohlo emva kwe-infarction ye-myocardial, kunye ne-nephropathy yesifo sikashukela.Kunyango lwe-hypertension eyimfuneko, i-captopril ithathwa njengonyango lokuqala, nokuba yodwa okanye idityaniswe ne-thiazide diuretic.Ukwehla koxinzelelo lwegazi kubalelwa ikakhulu kukuncipha kokunganyangeki kwe-peripheral okanye ukulayisha emva.Inzuzo yokudibanisa unyango lwe-captopril kunye ne-thiazide diuretic yesiqhelo kukuba i-hypokalemia eyenziwe yi-thiazide iyancitshiswa xa kukho isithintelo se-ACE, kuba kukho ukuhla okubonakalayo kokukhutshwa kwe-aldosterone ye-angiotensin II.
